21 C.F.R. § 1310.11

Reinstatement of exemption for drug products distributed under the Food, Drug and Cosmetic Act.

Last amended: 2016Year: 2026Length: 163 wordsSubsections: 4Official source

Cite as 21 C.F.R. § 1310.11 (2026)

(a) The Administrator has reinstated the exemption for the drug products listed in paragraph (e) of this section from application of sections 302, 303, 310, 1007, and 1008 of the Act (21 U.S.C. 822-823, 830, and 957-958), to the extent described in paragraphs (b), (c), and (d) of this section. (b) No reinstated exemption granted pursuant to 1310.10 affects the criminal liability for illegal possession or distribution of listed chemicals contained in the exempt drug product. (c) Changes in exempt drug product compositions: Any change in the quantitative or qualitative composition, trade name or other designation of an exempt drug product listed in paragraph (d) requires a new application for reinstatement of the exemption. (d) The following drug products, in the form and quantity listed in the application submitted (indicated as the “date”) are designated as reinstated exempt drug products for the purposes set forth in this section: Exempt Drug Products Supplier Product name Form Date [Reserved] [60 FR 32462, June 22, 1995]
Cross-references to the US Code
21:822-823
21 C.F.R. § 1310.11: Reinstatement of exemption for drug products distributed under the Food, Drug and Cosmetic Act. | Justis AI